Venlafaxine Hydrochloride
Product Images NDC 50090-2894

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 50090-2894). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 01

A chart showing the pharmacokinetic fold change and 90% confidence interval recommendations for venlafaxine when co-administered with various interacting drugs including ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium. The chart compares changes in Cmax and AUC relative to a reference value, with dosage adjustment advice provided for each interacting drug.*

FDA Label Image

E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 02

A figure showing fold change values (Cmax and AUC) with 90% confidence intervals for various interacting drugs with venlafaxine hydrochloride. The horizontal axis represents change relative to a reference value from 0 to 3, and drug interaction recommendations such as dose adjustments or usage precautions are listed alongside the data points.*

FDA Label Image

E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 03

A scatter plot chart showing fold change and 90% confidence intervals for pharmacokinetic parameters Cmax and AUC of venlafaxine and its ODV metabolite across different special populations. Populations include hepatic cirrhosis, mild and moderate hepatic impairment, renal impairment including hemodialysis, CYP2D6 polymorphism, age over 60, and gender. Recommendations on dose adjustments are shown to the right, varying from no dose adjustment to dose reductions by 25-50% or greater depending on the condition.*

FDA Label Image

E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 04

Chemical structure of venlafaxine hydrochloride, showing the molecular arrangement including a cyclohexanol ring, methoxy phenyl group, and dimethylamino ethyl side chain with hydrochloride indicated.*

FDA Label Image

Label Image (Lbl500902886)

Venlafaxine hydrochloride 37.5 mg extended-release capsules carton label from A-S Medication Solutions. The label specifies 30 extended-release capsules, each equivalent to 37.5 mg venlafaxine base. Storage instructions note to keep at 68 to 77 degrees F. It includes dosage and packaging details with NDC 50090-2886-0.*

FDA Label Image

Label Image (Lbl500902894)

The image shows a venlafaxine hydrochloride 75 mg extended-release capsules label from A-S Medication Solutions, Libertyville, IL 60048. The label lists the product number (9052-0) and the NDC number (50090-2894-0). It includes storage instructions to keep between 60 to 77 degrees Fahrenheit and notes a quantity of 29 extended-release capsules in the package.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.